Bronstein, Gewirtz & Grossman, LLC Notifies AbbVie, Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm Pharmaceutical Investing
AUPH LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Aurinia Pharmaceuticals Inc. Pharmaceutical Investing
Aptose Receives Fast Track Designation for HM43239 in Relapsed/Refractory AML Patients and FLT3 Mutation Market News
Aurinia Pharmaceuticals Investors: Class action lawsuit filed on behalf of investors; the Portnoy Law Firm Pharmaceutical Investing
Bristol Myers Squibb to Participate in Bank of America Securities 2022 Healthcare Conference Pharmaceutical Investing
ROSEN, A TOP RANKED FIRM, Encourages Aurinia Pharmaceuticals Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AUPH Pharmaceutical Investing
ROSEN, RESPECTED INVESTOR COUNSEL, Encourages AbbVie Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ABBV Pharmaceutical Investing
Ongoing Investigation Reminder: The Schall Law Firm Encourages Investors in Amgen Inc. with Losses of $100,000 to Contact the Firm Market News
Important Shareholder Reminder: Kessler Topaz Meltzer & Check, LLP Reminds AbbVie, Inc. Shareholders of Deadline in Securities Fraud Class Action Lawsuit Pharmaceutical Investing
Ongoing Investigation Alert: The Schall Law Firm Encourages Investors in Amgen Inc. with Losses of $100,000 to Contact the Firm Market News
